Arnuity Ellipta of GlaxoSmithkline has been approved by US FDA for maintenance treatment of Asthma as prophylactic therapy in 12 years or older patients.
Arunity Ellipta (fluticasone furoate ) is an inhalation powder which is a once -daily inhaled corticosteroid medicine with doses of 100 mcg and 200 mcg.
However,it is not indicated for relief of acute bronchospasm.
Arunity Ellipta (fluticasone furoate ) is an inhalation powder which is a once -daily inhaled corticosteroid medicine with doses of 100 mcg and 200 mcg.
However,it is not indicated for relief of acute bronchospasm.